Skip to main content

NewAmsterdam Pharma Co N.V.

NAMSW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001936258

In the last 90 days, NewAmsterdam Pharma Co N.V. insiders filed 1 open-market purchase and 3 sales; 9 institutions reported holding it in 13F filings for Q2 2026, worth $28.1M in total; no superinvestor holds it.

Other share classesNAMS

Q2 2025 vs. Q1 2025

How the institutions holding NewAmsterdam Pharma Co N.V. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of NAMSW: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders10100
Shares1.31M1.30M−3.14K (−0.2%)
Value$12.3M$10.4M−$1.89M (−15.3%)

New holders (0)

Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q2 2025 but not at the end of Q1 2025.

None.

Sold out (0)

Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q1 2025 and filed for Q2 2025 without it.

None.